Last week in GLP1 (2025/09/15)

GLP1.Guide Staff

14 Sep 2025 — 1 min read

Here’s what happened last week in the GLP1 ecosystem:

🧑‍⚖️ Lawsuits over the negative side effects of GLP1s

🌐 The WHO is building a guideline for GLP1 use and requesting comments

🎭 Celebrity endorsements continue: Andy Cohen reveals use of GLP1s for weight management

🚨 GLP1 is now being used in SMS scams

📰 More anecdotal evidence of people not staying on GLP1s for over a year

Go deeper, learn more

Here are our latest deep dives on the recent news and research behind GLP1s:

We mostly hear of increased adoption of GLP1s in the mainstream — entertainers and public figures being quizzed on whether they use it or not, spectacular transformations for patients who have found a GLP1 that works for them, etc. Silicon Valley and those that like to experiment or “bio-hack” were very

An under-reported negative side effect: CVS

Keeping track of negative side effects of GLP1s is just as important (if not more important) than keeping track of positive side effects. Cyclic Vomiting Syndrome is a *rare* negative side effect that doesn’t come up in the research very often, but after hearing anecdotal reports of this side

Last week in GLP1 (2025/09/08)

Here’s what happened last week in the GLP1 ecosystem: 🌎 World Health Organization (WHO) adds GLP1 to essential medicines list (for diabetes) 🏛️ FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S. 🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s 📰 GLP-1 Receptor

Last week in GLP1 (2025/09/01)

Here’s what happened last week in the GLP1 ecosystem: 📑 Orforglipron Phase 3 trial results landed 📢 TEVA Pharmaceuticals announced FDA approval for weight loss with Liraglutide 🎤 Meghan Trainor has been in the news after a GLP1 transformation 🎾 Serena Williams has shared her GLP1 story Go deeper, read more Here are